Plenary Presentations
BHIVA is grateful to the speakers who have given their permission for their presentations to be available after the BHIVA 2009 conference and these can be downloaded from the links below.
BHIVA Review Session
Top ten papers 2008-09
Dr Andrew Ustianowski, North Manchester General Hospital
BHIVA Invited Lecture 1
Social Care standards for people with HIV
Dame Denise Platt, National AIDS Trust
BHIVA Invited Lecture 2
Rheumatological manifestations and HIV
Dr Karen Walker-Bone, Brighton and Sussex Medical School
BHIVA Plenary Session 1
Cerebrovascular disease in HIV
Professor Alan Bryer, University of Cape Town, South Africa
BHIVA Plenary Session 1
Endothelial function in HIV
Dr Giovanni Guaraldi, University of Modena, Italy
BHIVA Plenary Session 2
Emerging treatments and strategies for hepatitis C: Potential benefits in the coinfected
Dr Ashley Brown, Imperial College, London, UK
BHIVA Audit Session
Management of tuberculosis in HIV co-infected patients
Dr Matthijis Backx, University Hospital of Wales, Cardiff
BHIVA Plenary Session 3
Life expectancy in HIV
Professor Matthias Egger, University of Bern, Switzerland
BHIVA Plenary Session 4
Novel Strategies to Treat Naive Patients
Dr Mark Nelson, Chelsea and Westminster Hospital, London
BHIVA Plenary Session 4
HAART Failure in resource-limited settings: how to diagnose and what to do
Professor Anthony Harries, London School of Hygeine and Tropical Medicine
BHIVA Lunchtime Workshop 1
Clinico-pathological SpR Case Presentations
Dr Darren Cousins, Manchester Royal Infirmary | Dr Jake Dunning, Chelsea and Westminister Hospital, London | Dr Sheel Patel, Mayday University Hospital, London | Dr Shema Tariq, City University, London
BHIVA Lunchtime Workshop 2
Difficult Pharmacology SpR Case Presentations
Dr Tristan Barber, Mortimer Market Centre, London | Dr Amelia Hughes, Chelsea and Westminster Hospital, London | Dr Ashini Jayasuriya, Birmingham Heartlands Hospital | Dr Michael Rayment, Chelsea and Westminster Hospital, London
Oral Presentations
BHIVA is grateful to the speakers who have given their permission for their presentations to be available after the BHIVA 2009 conference. These can be downloaded from the links below.
Session 1 - Wednesday 1st April 2009
Evaluation of peripheral DEXA as a screening tool for osteoporosis in an HIV seropositive male population
Dr CS Short, Royal Sussex County Hospital, Brighton
Continuation of BID Boosted PI vs Switch to Once-daily Boosted Atazanavir in Subjects with Lipohypertrophy
Dr P Hay, St George’s Hospital, London
Does Interruption of ART in Acute HIV infection alter surrogate biomarkers of cardiovascular disease? A pilot study.
Dr E Hamlyn, Imperial College London
Clinical epidemiology of end-stage renal failure (ESRF) in the UK
Dr A Hughes, Chelsea and Westminster Hospital, London
Prevalence and Risk factors for Vitamin D deficiency in a South London HIV Cohort: Which drugs are implicated?
Dr T Welz, King’s College Hospital, London
Session 2 - Wednesday 1st April 2009
Does Point-of-Care Testing Improve Acceptance of HIV Testing?
Dr P Khan, Homerton University Hospital, London
A decade of the Sperm-washing program: The effect of HIV on semen parameters and viral load
Dr JDM Nicopoullos, Chelsea and Westminster Hospital, London
HIV Testing In Termination Of Pregnancy Services
Dr S Creighton, Homerton University Hospital, London
Pregnancies in HIV-infected adolescents - A multicentre descriptive study
Dr A Elgalib, St Thomas’ Hospital, London
Session 3 - Thursday 2nd April 2009
HAART and the incidence of non-AIDS defining cancers in people with HIV infection
Dr T Powles, St Bartholomew’s Hospital, London
Excellent Immune Recovery Following the Intensive Chemotherapy CODOX-M/IVAC. An Effective Therapy for HIV-Associated Burkitt Lymphoma (HIV-BL)
Dr J Wilson, Royal Free Hospital, London
Session 4 - Thursday 2nd April 2009
Impact of recombinant human growth hormone on T-cell phenotype and function in vitro and in vivo during treated HIV-1 infection
Miss A Herasimtschuk, Imperial College, London
HIV transmission amongst MSM: association with infection stage, viraemia and STIs in a longitudinal phylogenetic study
Dr K Nambiar, Brighton and Sussex University Hospitals, NHS Trust
Session 5 - Thursday 2nd April 2009
Switching from Efavirenz to Nevirapine: A novel pharmacological strategy
Dr NE Dufty, Birmingham Heartlands Hospital, Birmingham
Nuclear receptor polymorphisms and boosted saquinavir plasma concentrations in HIV-infected subjects
Dr A Chaikan, University of Liverpool, Liverpool
Darunavir/ritonavir once daily: a single centre cohort experience
Dr C Scott, Chelsea and Westminster Hospital, London
Session 6 - Friday 3rd April 2009
Successful Primary Prevention of Cryptococcal Disease Using Fluconazole Prophylaxis in HIV Infected Ugandan Adults (CRYPTOPRO)
Dr R Parkes-Ratanshi, Imperial College, London
Multicentre surveillance study of hepatitis B virus (HBV) infection in HIV-infected patients: Evidence of transmitted and acquired HBV drug resistance
Dr T Doyle, University College London Medical School, London